Jorge Marcet

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Julio García‐Aguilar, Sujata Patil, Marc J. Gollub et al. · Journal of Clinical Oncology · 2022 · 906 citations · Full text

Medicine, Oncology, Surgery +17

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

Julio García‐Aguilar, Oliver S. Chow, David Smith et al. · The Lancet Oncology · 2015 · 698 citations · Full text

Medicine, Oncology, Chemotherapy +15

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

Julio García‐Aguilar, Lindsay A. Renfro, Oliver S. Chow et al. · The Lancet Oncology · 2015 · 424 citations · Full text

Medicine, Oncology, Surgery +17

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Floris S. Verheij, Dana M. Omer, Hannah Williams et al. · Journal of Clinical Oncology · 2023 · 321 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +1

A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial

Julio García‐Aguilar, Qian Shi, Charles R. Thomas et al. · Annals of Surgical Oncology · 2011 · 302 citations

Medicine, Oncology, Surgery +17